Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

Title: Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
Authors: Hindy, G; Tyrrell, DJ; Vasbinder, A; Wei, C; Presswalla, F; Wang, H; Blakely, P; Ozel, AB; Graham, S; Holton, GH; Dowsett, J; Fahed, AC; Michael Amadi, K; Erne, GK; Tekmulla, A; Ismail, A; Launius, C; Sotoodehnia, N; Pankow, JS; Thørner, LW; Erikstrup, C; Pedersen, OB; Banasik, K; Brunak, S; Ullum, H; Eugen-Olsen, J; Ostrowski, SR; Haas, ME; Nielsen, JB; Lotta, LA; Engström, G; Melander, O; Orho-Melander, M; Zhao, L; Murthy, VL; Pinsky, DJ; Willer, CJ; Heckbert, SR; Reiser, J; Goldstein, DR; Desch, KC; Hayek, SS
Publisher Information: American Society for Clinical Investigation
Publication Year: 2024
Collection: University of Michigan: Deep Blue
Subject Terms: Atherosclerosis; Cardiology; Innate immunity; Animals; Mice; Biomarkers; Genome-Wide Association Study; Monocytes; Proprotein Convertase 9; Receptors; Urokinase Plasminogen Activator; Risk Factors; Urokinase-Type Plasminogen Activator; Humans
Subject Geographic: United States
Description: People with kidney disease are disproportionately affected by atherosclerosis for unclear reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived mediator of kidney disease, levels of which are strongly associated with cardiovascular outcomes. We assessed suPAR's pathogenic involvement in atherosclerosis using epidemiologic, genetic, and experimental approaches. We found serum suPAR levels to be predictive of coronary artery calcification and cardiovascular events in 5,406 participants without known coronary disease. In a genome-wide association meta-analysis including over 25,000 individuals, we identified a missense variant in the plasminogen activator, urokinase receptor (PLAUR) gene (rs4760), confirmed experimentally to lead to higher suPAR levels. Mendelian randomization analysis in the UK Biobank using rs4760 indicated a causal association between genetically predicted suPAR levels and atherosclerotic phenotypes. In an experimental model of atherosclerosis, proprotein convertase subtilisin/kexin-9 (Pcsk9) transfection in mice overexpressing suPAR (suPARTg) led to substantially increased atherosclerotic plaques with necrotic cores and macrophage infiltration compared with those in WT mice, despite similar cholesterol levels. Prior to induction of atherosclerosis, aortas of suPARTg mice excreted higher levels of CCL2 and had higher monocyte counts compared with WT aortas. Aortic and circulating suPARTg monocytes exhibited a proinflammatory profile and enhanced chemotaxis. These findings characterize suPAR as a pathogenic factor for atherosclerosis acting at least partially through modulation of monocyte function. ; http://deepblue.lib.umich.edu/bitstream/2027.42/195723/2/Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis.pdf ; Published version
Document Type: article in journal/newspaper
File Description: Electronic; application/pdf
Language: English
Relation: ARTN e158788; https://www.ncbi.nlm.nih.gov/pubmed/36194491; https://hdl.handle.net/2027.42/195723; https://dx.doi.org/10.7302/24792; Journal of Clinical Investigation; 132; 24; e158788; Hindy, G; Vasbinder, A; Wei, C; Presswalla, F; Wang, H; Blakely, P; Ozel, AB; Graham, S; Holton, GH; Dowsett, J; Fahed, AC; Michael Amadi, K; Erne, GK; Tekmulla, A; Ismail, A; Launius, C; Sotoodehnia, N; Pankow, JS; Thørner, LW; Erikstrup, C; Pedersen, OB; Banasik, K; Brunak, S; Ullum, H; Ostrowski, SR; Haas, ME; Nielsen, JB; Lotta, LA; Engström, G; Melander, O; Zhao, L; Heckbert, SR; Reiser, J
DOI: 10.1172/JCI158788
DOI: 10.7302/24792
Availability: https://hdl.handle.net/2027.42/195723; https://www.ncbi.nlm.nih.gov/pubmed/36194491; https://doi.org/10.1172/JCI158788; https://doi.org/10.7302/24792
Rights: Licence for published version: Creative Commons Attribution 4.0 International ; http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.2D372657
Database: BASE